0001437749-18-013621.txt : 20180723 0001437749-18-013621.hdr.sgml : 20180723 20180723190241 ACCESSION NUMBER: 0001437749-18-013621 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180719 FILED AS OF DATE: 20180723 DATE AS OF CHANGE: 20180723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roshan Hanif A CENTRAL INDEX KEY: 0001664441 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20190 FILM NUMBER: 18965369 MAIL ADDRESS: STREET 1: C/O AEON CLINICAL LABORATORIEXS STREET 2: 2225 CENTENNIAL DRIVE CITY: GAINESVILLE STATE: FL ZIP: 30504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeon Global Health Corp. CENTRAL INDEX KEY: 0000885074 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 141673067 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2225 CENTENNIAL DRIVE CITY: GAINESVILLE STATE: 2Q ZIP: 30504 BUSINESS PHONE: 888-661-0225 MAIL ADDRESS: STREET 1: 2225 CENTENNIAL DRIVE CITY: GAINESVILLE STATE: 2Q ZIP: 30504 FORMER COMPANY: FORMER CONFORMED NAME: AUTHENTIDATE HOLDING CORP DATE OF NAME CHANGE: 20010327 FORMER COMPANY: FORMER CONFORMED NAME: BITWISE DESIGNS INC DATE OF NAME CHANGE: 19930328 4 1 rdgdoc.xml FORM 4 X0306 4 2018-07-19 0000885074 Aeon Global Health Corp. AGHC 0001664441 Roshan Hanif A AEON GLOBAL HEALTH CORP. 2225 CENTENNIAL DR. GAINESVILLE GA 30504 1 1 1 Chairman and CEO Convertible Note 1.20 2018-07-19 4 D 0 255417 0 D 2017-03-20 2019-03-20 Common Stock 212847 0 D Convertible Note 1.20 2018-07-19 4 D 0 504452 0 D 2018-03-27 2019-03-20 Common Stock 420376 0 D Restricted Stock Rights 2018-07-19 4 A 0 911500 0 A Common Stock 911500 911500 D Effective on July 19, 2018 the registrant entered into a transaction with the reporting person to exchange (i) a preexisting note originally issued to the reporting person on March 20, 2017 and amended on March 27, 2018 in the aggregate principal amount of $255,417 and (ii) a preexisting note originally issued to the reporting person on March 27, 2018 in the aggregate principal amount of $504,452 for a new secured note for a maximum principal amount of $1,100,000 (the "New Note"). The New Note is not convertible into any equity securities of the registrant. The preexisting notes held by the reporting person were deemed cancelled upon the issuance of the New Note pursuant to such exchange transaction. Represents the right to receive 911,500 shares of common stock on February 28, 2019 pursuant to the terms of a Settlement and Restructuring Agreement dated July 19, 2018 (the "Settlement Agreement") among the reporting person, the registrant and certain other parties named therein. The shares issuable under the Settlement Agreement will be deemed earned and issued on February 28, 2019. /s/ Hanif A. Roshan 2018-07-23